Channel Medsystems, Inc., the manufacturer of the Cerene® Cryotherapy Device (Cerene), is initiating a prospective, observational registry, the Progress registry, to gather data during real world utilization of the Cerene® Cryotherapy Device (Cerene). The primary objective of this registry is to bridge the gap between clinical results and outcomes achieved and reported during the pivotal study of Cerene and those obtained during its real-world use.
Heavy Menstrual Bleeding, Abnormal Uterine Bleeding, Menorrhagia
Channel Medsystems, Inc., the manufacturer of the Cerene® Cryotherapy Device (Cerene), is initiating a prospective, observational registry, the Progress registry, to gather data during real world utilization of the Cerene® Cryotherapy Device (Cerene). The primary objective of this registry is to bridge the gap between clinical results and outcomes achieved and reported during the pivotal study of Cerene and those obtained during its real-world use.
A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device
-
Axia Women's Health / Rubino OB/GYN Group, West Orange, New Jersey, United States, 07052
Axia Women's Health / Seven Hills Women's Health Centers, Cincinnati, Ohio, United States, 45255
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
25 Years to
FEMALE
No
Channel Medsystems,
Edward Yu, MBA, STUDY_CHAIR, Executive VP of Clinical, Medical, and Regulatory Affairs
2025-12-09